XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 1 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $14,000 | -53.3% | 5,744 | -21.7% | 0.00% | – |
| Q2 2021 | $30,000 | -14.3% | 7,334 | -5.8% | 0.00% | – |
| Q1 2021 | $35,000 | -49.3% | 7,787 | -44.5% | 0.00% | – |
| Q4 2020 | $69,000 | +15.0% | 14,021 | +39.1% | 0.00% | – |
| Q3 2020 | $60,000 | +106.9% | 10,082 | -9.3% | 0.00% | – |
| Q2 2020 | $29,000 | +61.1% | 11,116 | +17.4% | 0.00% | – |
| Q1 2020 | $18,000 | -99.9% | 9,472 | -99.6% | 0.00% | -100.0% |
| Q4 2019 | $15,523,000 | +46939.4% | 2,201,839 | +66662.9% | 0.01% | – |
| Q3 2019 | $33,000 | -68.0% | 3,298 | -63.6% | 0.00% | – |
| Q2 2019 | $103,000 | +74.6% | 9,060 | +54.6% | 0.00% | – |
| Q1 2019 | $59,000 | +136.0% | 5,859 | +300.2% | 0.00% | – |
| Q4 2018 | $25,000 | -24.2% | 1,464 | -20.9% | 0.00% | – |
| Q3 2018 | $33,000 | – | 1,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 4,172,459 | $20,528,000 | 1.31% |
| DELTEC ASSET MANAGEMENT LLC | 693,870 | $3,414,000 | 0.52% |
| Alpine Global Management, LLC | 350,000 | $1,722,000 | 0.35% |
| Redmile Group, LLC | 2,397,441 | $11,795,000 | 0.14% |
| Kamunting Street Capital Management, L.P. | 43,833 | $216,000 | 0.11% |
| IHT Wealth Management, LLC | 250,798 | $1,234,000 | 0.10% |
| SEARLE & CO. | 34,000 | $167,000 | 0.08% |
| GPS Wealth Strategies Group, LLC | 46,025 | $226,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,981,909 | $9,751,000 | 0.08% |
| Gladstone Institutional Advisory LLC | 51,500 | $253 | 0.05% |